| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.21 | 0.4 |